How to buy US stocks & ETFs from India
70 single-stock guides and 20 ETF guides covering the major US-listed names, written for Indian residents. Every guide walks through legality under the LRS, the brokerage choice, the Section 112 capital-gains math in rupees, dividend withholding where the security pays one, the $60,000 US estate-tax trap, and our explicit editorial verdict — Buy, Hold, or Sell.
How to read these guides
Each guide assumes you are an Indian resident. The mechanics covered are RBI's Liberalised Remittance Scheme (USD 250,000 per financial year), 20% TCS above ten lakh rupees of remittance (creditable, not a cost), Section 112 long-term capital gains at 12.5% after 24 months with no indexation, the 25% US DTAA dividend withholding rate via W-8BEN, Form 67 foreign tax credit (transitioning to Form 44 from TY 2026-27), Schedule FA disclosure every year you hold, and the $60,000 US-situs estate-tax trap on directly-held US stocks. We label our verdict on every guide and back it up — the verdicts are editorial opinions for educational illustration only, not regulated SEBI investment advice.
New to global investing? Start with the master guide →
US ETFs
20 guidesIndex, sector, dividend, factor, bond, and commodity ETFs an Indian resident can buy via the LRS. Same tax framing as single stocks — Section 112 LTCG on capital gains, 25% US DTAA withholding on dividends, $60,000 estate-tax trap on US-domiciled funds.
Broad-market US
Total-market and S&P 500 trackers — the canonical core-holding ETFs for an Indian investor wanting US exposure.
Developed international (ex-US)
Developed markets outside the US — Europe, Japan, Australia, Canada.
Emerging markets
Broad emerging-markets exposure — China, India, Korea, Taiwan, Brazil, and the rest.
Total international
Single-ticker exposure to the whole world outside the US.
Dividend & income
High-yield and dividend-growth ETFs — sticky income with US-source dividend withholding to manage.
Factor (value / growth)
Value vs growth tilts — for investors who want a deliberate factor lean on top of a broad index.
Sector & thematic
Semiconductors, innovation, and theme-led exposure — concentrated bets on a single category.
Small-cap
US small-company exposure beyond the megacap-led S&P 500.
Bonds
US bond-market exposure for asset allocation — note the Indian tax treatment differs from equity.
Commodities
Gold and other commodity exposure via US-listed ETFs.
Single stocks
Every name we cover, grouped by sector and theme.
Mega-cap tech
The largest US-listed technology platforms — search, cloud, devices, advertising.
Semiconductors & semi-cap-equipment
Chipmakers and the equipment used to fabricate them — AI cycle's most-leveraged exposure.
- Analog DevicesADIHOLDUpdated 21 Nov 2025
- Applied MaterialsAMATBUYUpdated 16 Dec 2025
- ARM HoldingsARMHOLDUpdated 28 Mar 2026
- ASMLASMLBUYUpdated 22 Dec 2025
- BroadcomAVGOBUYUpdated 21 Jan 2026
- IntelINTCSELLUpdated 4 Mar 2026
- KLAKLACBUYUpdated 12 Dec 2025
- Lam ResearchLRCXBUYUpdated 14 Dec 2025
- Microchip TechnologyMCHPHOLDUpdated 17 Nov 2025
- MicronMUHOLDUpdated 22 Mar 2026
- NXP SemiconductorsNXPIHOLDUpdated 19 Nov 2025
- QualcommQCOMHOLDUpdated 16 Mar 2026
- Texas InstrumentsTXNHOLDUpdated 23 Nov 2025
AI & data-center infrastructure
Power, cooling, networking, and platform companies riding the AI capex super-cycle.
Cybersecurity
Identity, network, endpoint, and cloud-security platforms benefitting from enterprise consolidation.
Software & SaaS
Vertical and horizontal SaaS companies — enterprise productivity, design, dev tools, observability.
- AdobeADBEHOLDUpdated 14 Feb 2026
- AppLovinAPPHOLDUpdated 13 Nov 2025
- AtlassianTEAMHOLDUpdated 22 Apr 2026
- Cadence Design SystemsCDNSBUYUpdated 27 Nov 2025
- DatadogDDOGBUYUpdated 1 Nov 2025
- IntuitINTUBUYUpdated 16 Apr 2026
- SalesforceCRMHOLDUpdated 20 Feb 2026
- ServiceNowNOWBUYUpdated 26 Feb 2026
- SynopsysSNPSBUYUpdated 25 Nov 2025
- TwilioTWLOHOLDUpdated 28 Apr 2026
- WorkdayWDAYHOLDUpdated 16 May 2026
Consumer internet & marketplaces
E-commerce, gig economy, streaming, and the major online consumer platforms.
Consumer staples
Snacks, beverages, retail — defensive cash-flow compounders with dividend stories.
Fintech & payments
Card networks, digital wallets, and embedded-finance leaders.
Biotech & pharma
Large-cap biotech with on-market franchises and pipelines — typically dividend-paying or in cash-rich phase.
Medtech & medical devices
Robotic surgery, continuous glucose monitoring, imaging — quality medical-device franchises.
Industrial conglomerates
Diversified industrials with US-listed scale and global footprint.
Media, entertainment & gaming
Studios, streaming, game publishers, and pending corporate-action stories.
Telecom
US wireless and integrated telecom — post-Sprint consolidation winners and dividend stories.
Travel & hospitality
Hotel operators, online-travel aggregators, and short-term-rental marketplaces.
Crypto & Bitcoin proxies
Listed companies that give equity exposure to crypto without holding the asset directly.
IT services
Large-cap IT services and consulting — high Indian-employee base for RSU readers.
Storage & hardware
HDD, NAND, and enterprise-storage companies through the AI-data-center storage cycle.
Important compliance note
Vested.blog is not a SEBI-registered Research Analyst. Buy / Hold / Sell verdicts shown above are editorial opinions written for educational illustration only — they are not investment advice, not regulated stock recommendations, and should not be treated as such. Vested.blog is published by Rovia; the publisher and its affiliates may hold positions in any stock discussed. For decisions specific to you, please consult a SEBI-registered investment advisor and a qualified Chartered Accountant.